XEDGE Trademark

Trademark Overview


On Tuesday, January 28, 2020, a trademark application was filed for XEDGE with the United States Patent and Trademark Office. The USPTO has given the XEDGE trademark a serial number of 88776048. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 15, 2021. This trademark is owned by Pfizer Inc.. The XEDGE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use
xedge

General Information


Serial Number88776048
Word MarkXEDGE
Filing DateTuesday, January 28, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 15, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the wordmark "XEDGE" with a bar above it; black on the left and fading to grey on the right.
Goods and ServicesPharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, liver disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations and smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 3, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Tuesday, February 16, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 15, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 9, 2020ASSIGNED TO EXAMINER
Tuesday, February 4, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, February 3, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 31, 2020NEW APPLICATION ENTERED IN TRAM